Brookfield
BN
36.98
-0.31
-0.83%
Brookfield
US · BN
#262 by market cap
Listed 1970
36.98
-0.31
-0.83%
Live - 5344 symbols - heartbeat 401s ago
· 2026-10-08 07:37
Pre-market
36.90
-0.22%
After-hours
37.00
+0.05%
Overnight
36.84
-0.38%
- Market cap
- 82.55B
- P/E (TTM)i
- 68.48
- P/Bi
- 1.95
- EPSi
- 0.49
- Div yieldi
- 0.70%
- 52W posi
- 10%
Reader sentiment
Are you bullish or bearish on BN?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 0.42, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -12.68% YoY
Margins
- Gross margin
- 24.14%
- Operating margin
- 24.03%
- Net margin
- 1.52%
Key ratios & quality
- Enterprise valuei
- 318.56B
- Altman Z-Scorei
- 0.42
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 56.77B | 67.83B | 62.75B | 75.73B | 92.77B | 95.92B | 86.01B | 75.10B |
| Gross profit | 11.25B | 15.10B | 9.58B | 11.73B | 14.26B | 14.52B | 18.07B | 18.13B |
| Selling & admin expenses | -- | -- | -- | 116.00M | 122.00M | 69.00M | 76.00M | -- |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 8.05B | 10.12B | 9.47B | 11.62B | 14.14B | 14.45B | 17.99B | 18.05B |
| Pretax profit | 7.24B | 5.85B | 1.54B | 14.71B | 6.66B | 6.12B | 2.84B | 4.37B |
| Tax | -248.00M | 495.00M | 837.00M | 2.32B | 1.47B | 1.01B | 982.00M | 1.14B |
| Net profit | 7.49B | 5.35B | 707.00M | 12.39B | 5.20B | 5.11B | 1.85B | 3.24B |
| Basic EPS | 2 | 1 | 0 | 2 | 1 | 0 | 0 | 1 |
| Diluted EPS | 1.51 | 1.15 | -0.08 | 1.59 | 0.79 | 0.41 | 0.20 | 0.49 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 17.94B | 18.08B | 18.92B | 20.16B | 18.58B | 19.41B |
| Gross profit | 4.49B | 4.17B | 4.29B | 5.18B | 4.44B | 4.47B |
| Selling & admin expenses | 18.00M | 20.00M | -- | -- | -- | -- |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 4.48B | 4.15B | 4.27B | 5.16B | 4.42B | 4.45B |
| Pretax profit | 598.00M | 1.19B | 788.00M | 1.80B | 1.44B | 1.04B |
| Tax | 383.00M | 134.00M | 504.00M | 114.00M | 398.00M | 336.00M |
| Net profit | 215.00M | 1.06B | 284.00M | 1.68B | 1.04B | 703.00M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.01 | 0.10 | 0.08 | 0.30 | 0.03 | 0.14 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 30.45B | 34.80B | 41.86B | 56.27B | 53.39B | 46.70B | 56.18B | 65.08B |
| Cash & ST investments | 11.77B | 10.38B | 15.42B | 19.66B | 21.96B | 16.89B | 20.18B | 23.60B |
| Inventory | 4.58B | 7.05B | 6.34B | 8.56B | 9.11B | 7.06B | 5.42B | 5.92B |
| Total assets | 256.28B | 323.97B | 343.70B | 391.00B | 441.28B | 490.10B | 490.42B | 518.97B |
| Total current liabilities | 26.31B | 40.62B | 49.50B | 65.08B | 77.75B | 91.13B | 72.31B | 76.99B |
| Short-term debt | 11.16B | 15.71B | 21.29B | 32.79B | 43.30B | 57.60B | 37.46B | 38.81B |
| Long-term debt | 107.06B | 127.66B | 127.11B | 143.14B | 170.78B | 176.11B | 197.33B | 220.80B |
| Total liabilities | 159,131,000,000.00 | 207,123,000,000.00 | 221,054,000,000.00 | 256,262,000,000.00 | 299,393,000,000.00 | 321,853,000,000.00 | 325,041,000,000.00 | 352,777,000,000.00 |
| Total equity | 97.15B | 116.85B | 122.64B | 134.74B | 141.89B | 168.24B | 165.38B | 166.19B |
| Retained earnings | 14.24B | 16.03B | 15.18B | 17.71B | 18.01B | 18.01B | 17.07B | 16.67B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 65.21B | 70.65B | 67.51B | 65.08B | 59.47B | 65.99B |
| Cash & ST investments | 12.44B | 22.85B | 25.39B | 23.60B | 19.69B | 19.97B |
| Inventory | 8.71B | 6.01B | 6.05B | 5.92B | 6.52B | 7.23B |
| Total assets | 491.58B | 506.07B | 514.59B | 518.97B | 519.61B | 525.52B |
| Total current liabilities | 59.94B | 80.85B | 79.82B | 76.99B | 72.22B | 84.88B |
| Short-term debt | 1.15B | 40.91B | 43.70B | 38.81B | 34.24B | 42.76B |
| Long-term debt | 244.72B | 209.72B | 215.51B | 220.80B | 229.49B | 222.22B |
| Total liabilities | 332,647,000,000.00 | 344,423,000,000.00 | 351,506,000,000.00 | 352,777,000,000.00 | 353,971,000,000.00 | 358,879,000,000.00 |
| Total equity | 158.93B | 161.65B | 163.08B | 166.19B | 165.64B | 166.64B |
| Retained earnings | 16.45B | 16.25B | 16.20B | 16.67B | 16.16B | 16.21B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 5.16B | 6.33B | 8.34B | 7.87B | 8.75B | 6.47B | 7.57B | 10.96B |
| Depreciation & amortization | 3.10B | 4.88B | 5.79B | 6.44B | 7.68B | 9.08B | 9.74B | 10.38B |
| Free cash flow | 3.20B | 3.28B | 4.33B | 993.00M | 1.52B | -1.60B | -3.60B | -3.79B |
| Dividends paid | -726.00M | -772.00M | -867.00M | -1.49B | -1.03B | -602.00M | -663.00M | -719.00M |
| Stock buybacks / issuance | -378.00M | -254.00M | -402.00M | -345.00M | -672.00M | -575.00M | -982.00M | -1.00B |
| Ending cash balance | 8.39B | 6.78B | 9.93B | 12.69B | 14.40B | 11.22B | 15.05B | 16.24B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 1.69B | 2.01B | 3.01B | 4.25B | 225.00M | 1.87B |
| Depreciation & amortization | 2.46B | 2.53B | 2.69B | 2.70B | 2.63B | 2.71B |
| Free cash flow | -1.12B | -745.00M | -930.00M | -998.00M | -5.68B | -1.81B |
| Dividends paid | -178.00M | -180.00M | -180.00M | -181.00M | -204.00M | -202.00M |
| Stock buybacks / issuance | -567.00M | -289.00M | -40.00M | -104.00M | -436.00M | -108.00M |
| Ending cash balance | 12.44B | 13.70B | 16.68B | 16.24B | 15.03B | 14.89B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 13.39 | 9.13 | -0.58 | 10.26 | 4.66 | 2.37 | 1.13 | 2.66 |
| ROA %i | 1.48 | 0.89 | -0.05 | 1.03 | 0.46 | 0.21 | 0.10 | 0.23 |
| ROIC %i | 5.60 | 5.80 | 2.89 | 5.11 | 4.35 | 5.23 | 4.08 | 4.76 |
| 5-year avg ROE %i | 10.42 | 9.13 | 6.90 | 7.57 | 7.37 | 5.17 | 3.57 | 4.22 |
| EBIT margin %i | 21.30 | 19.28 | 13.95 | 29.47 | 18.72 | 22.54 | 22.61 | 28.59 |
| FCF / sales %i | 5.63 | 4.83 | 6.90 | 1.31 | 1.63 | -- | -- | -- |
| Current ratioi | 1.16 | 0.86 | 0.85 | 0.86 | 0.69 | 0.51 | 0.78 | 0.85 |
| Quick ratioi | 0.90 | 0.60 | 0.60 | 0.55 | 0.53 | 0.41 | 0.56 | 0.60 |
| Debt / assetsi | 46.13 | 44.26 | 43.18 | 45.00 | 48.51 | 47.69 | 47.88 | 50.02 |
| LT debt / equityi | 417.43 | 413.57 | 401.08 | 339.12 | 431.17 | 422.58 | 471.24 | 504.15 |
| Interest coveragei | 2.49 | 1.81 | 1.21 | 2.93 | 1.62 | 1.39 | 1.17 | 1.26 |
| Revenue CAGR (3Y) %i | 41.80 | 40.58 | 15.44 | 10.08 | 11.00 | 15.19 | 4.33 | -6.80 |
| Net income CAGR (3Y) %i | 15.25 | 19.35 | -- | 3.43 | -9.86 | -- | -45.53 | -14.02 |
| FCF CAGR (3Y) %i | 24.07 | 26.68 | 23.20 | -32.28 | -22.66 | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 1.09 | 1.61 | 1.96 | 2.66 | 2.78 | 2.96 |
| ROA %i | 0.09 | 0.13 | 0.16 | 0.23 | 0.23 | 0.24 |
| ROIC %i | 4.53 | 4.64 | 4.46 | 4.76 | 4.93 | 4.69 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 23.79 | 26.98 | 26.41 | 28.59 | 29.71 | 29.30 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 1.09 | 0.87 | 0.85 | 0.85 | 0.82 | 0.78 |
| Quick ratioi | 0.72 | 0.56 | 0.60 | 0.60 | 0.59 | 0.51 |
| Debt / assetsi | 50.02 | 49.53 | 50.37 | 50.02 | 50.76 | 50.42 |
| LT debt / equityi | 594.55 | 493.54 | 506.43 | 504.15 | 537.49 | 523.09 |
| Interest coveragei | 1.16 | 1.23 | 1.18 | 1.26 | 1.30 | 1.29 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- Private equity is the largest reported line at 36.14% of revenue, across 7 reported segments.
- No single line clears half of revenue; Infrastructure is next at 34.63%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
Private equity36.14%
Infrastructure34.63%
Asset Management18.16%
Energy10.56%
Real estate6.31%
Corporate Activities0.61%
Quote time 2026-10-08 07:37:41 · For reference only, not investment advice and not tailored to your situation.